102 related articles for article (PubMed ID: 35313615)
1. Boosters reduce in-hospital mortality in patients with COVID-19: An observational cohort analysis.
Mielke N; Johnson S; Bahl A
Lancet Reg Health Am; 2022 Apr; 8():100227. PubMed ID: 35313615
[TBL] [Abstract][Full Text] [Related]
2. Predictors of hospitalization and severe disease due to breakthrough SARS-CoV-2 infection in fully vaccinated individuals.
Johnson S; Mielke N; Mathew T; Maine GN; Chen NW; Bahl A
J Am Coll Emerg Physicians Open; 2022 Aug; 3(4):e12793. PubMed ID: 35919515
[TBL] [Abstract][Full Text] [Related]
3. Vaccination reduces need for emergency care in breakthrough COVID-19 infections: A multicenter cohort study.
Bahl A; Johnson S; Maine G; Garcia MH; Nimmagadda S; Qu L; Chen NW
Lancet Reg Health Am; 2021 Dec; 4():100065. PubMed ID: 34522911
[TBL] [Abstract][Full Text] [Related]
4. Updated Bivalent COVID-19 Vaccines Reduce Risk of Hospitalization and Severe Outcomes in Adults: An Observational Cohort Study.
Mielke N; Johnson S; O'Sullivan C; Toseef MU; Bahl A
J Clin Med Res; 2024 May; 16(5):208-219. PubMed ID: 38855782
[TBL] [Abstract][Full Text] [Related]
5. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals.
Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH
JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Vaccination Against SARS-CoV-2 Virus on the Outcome of COVID-19 Disease.
AlKhafaji DM; Al Argan RJ; AlBahrani S; Alwaheed AJ; Alqatari SG; Al Elq AH; Albaker W; Alwazzeh M; AlSulaiman AS; AlSulaiman RS; Almadan HM; Alhammad AA; Almajid AN; Hakami FH; Alanazi WK
Infect Drug Resist; 2022; 15():3477-3489. PubMed ID: 35813086
[TBL] [Abstract][Full Text] [Related]
7. Course and Lethality of SARS-CoV-2 Epidemic in Nursing Homes after Vaccination in Florence, Italy.
Rivasi G; Bulgaresi M; Mossello E; Buscemi P; Lorini C; Balzi D; Barucci R; Del Lungo I; Gangemi S; Giardini S; Piga C; Barghini E; Boni S; Bulli G; Carrai P; Crociani A; Faraone A; Lo Forte A; Martella L; Pupo S; Fortini G; Marozzi I; Bandini G; Cosma C; Stacchini L; Vaccaro G; Baggiani L; Landini G; Bonaccorsi G; Ungar A; Benvenuti E
Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696282
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
[TBL] [Abstract][Full Text] [Related]
9. The Effectiveness of SARS-CoV-2 Vaccination in Preventing Severe Illness and Death - Real-world Data from a Cohort of Patients Hospitalized with COVID-19.
Sagiraju HKR; Elavarasi A; Gupta N; Garg RK; Paul SS; Vig S; Sirohiya P; Ratre B; Garg R; Pandit A; Singh R; Kumar B; Meena VP; Wig N; Mittal S; Pahuja S; Madan K; Das N; Dwivedi T; Gupta R; Wundavalli L; Singh AR; Singh S; Mishra A; Pandey M; Matharoo KS; Kumar S; Mohan A; Guleria R; Bhatnagar S
Indian J Community Med; 2022; 47(4):510-516. PubMed ID: 36742977
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and respiratory care in hospitalized vaccinated SARS-CoV-2 patients.
Teran-Tinedo JR; Gonzalez-Rubio J; Najera A; Castany-Faro A; Contreras MLN; Garcia IM; Lopez-Mellado L; Lorente-Gonzalez M; Perez-Garvin P; Sacristan-Crespo G; Suarez-Ortiz M; Navarro-Lopez JD; Jimenez-Diaz L; Landete P
EClinicalMedicine; 2022 Jun; 48():101453. PubMed ID: 35611064
[TBL] [Abstract][Full Text] [Related]
12. Description of Hospitalizations due to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Based on Vaccination Status.
Moffa MA; Shively NR; Carr DR; Bremmer DN; Buchanan C; Trienski TL; Jacobs MW; Saini V; Walsh TL
Open Forum Infect Dis; 2022 Sep; 9(9):ofac438. PubMed ID: 36092825
[TBL] [Abstract][Full Text] [Related]
13. Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults.
Myers LC; Kipnis P; Greene J; Lawson B; Escobar GJ; Fireman BH; Klein NP; Liu VX
J Intern Med; 2022 Aug; 292(2):377-384. PubMed ID: 35531712
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccination improved outcomes in the treatment of geriatric hip fractures between December 2020 and January 2022.
Konda SR; Meltzer Bruhn AT; Esper GW; Solasz SJ; Ganta A; Egol KA
Hip Int; 2023 Nov; 33(6):1133-1139. PubMed ID: 36703257
[TBL] [Abstract][Full Text] [Related]
16. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
17. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE
Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623
[TBL] [Abstract][Full Text] [Related]
18. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525
[TBL] [Abstract][Full Text] [Related]
20. Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study.
Bruxvoort KJ; Sy LS; Qian L; Ackerson BK; Luo Y; Lee GS; Tian Y; Florea A; Takhar HS; Tubert JE; Talarico CA; Tseng HF
Lancet Reg Health Am; 2022 Feb; 6():100134. PubMed ID: 34849505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
